| human | Q5 |
| P10058 | IRIS UNIBO author ID | 121889 |
| P496 | ORCID iD | 0000-0001-5686-720X |
| P1053 | ResearcherID | K-3366-2018 |
| P1153 | Scopus author ID | 6603812291 |
| P108 | employer | Rizzoli Orthopedic Institute | Q3803656 |
| P735 | given name | Maria | Q325872 |
| Maria | Q325872 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q40378150 | 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients. |
| Q56378218 | A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy |
| Q35103838 | An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. |
| Q40427655 | Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. |
| Q38352962 | Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). |
| Q44438546 | C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. |
| Q34483649 | CD99 acts as an oncosuppressor in osteosarcoma |
| Q34629236 | CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. |
| Q38929303 | CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin |
| Q40093820 | Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. |
| Q39026978 | Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications |
| Q42453605 | Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospects |
| Q39033443 | Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells |
| Q40707005 | Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. |
| Q54386341 | Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival. |
| Q34159317 | Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells. |
| Q40572224 | Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene. |
| Q39314094 | Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma. |
| Q28244685 | In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type |
| Q40298751 | Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma. |
| Q112781839 | Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma |
| Q28538155 | Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug |
| Q34325539 | Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. |
| Q39869264 | Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome |
| Q90871923 | Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid Asymmetry |
| Q112767238 | Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma |
| Q40344079 | Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma |
| Q53240644 | Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy. |
| Q35788810 | The expression of ccn3(nov) gene in musculoskeletal tumors |
| Q38917815 | Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents. |
| Q39465507 | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
Search more.